Please assess the completion status of the following clinical trial:

Trial Title: Glycemic Control and Surgical Site Infection Incidence Among Liver Transplantation Recipients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Recipients of LT whose allograft came from deceased donors~* Able to give informed consent personally or via a family member who has appropriate authorization to do so if patient unconscious.~* Blood glucose level over 130 mg/dL in the first 24 hours postoperatively~Exclusion Criteria:~* The patients that underwent any kind of surgery with or without prosthesis implant in the 30 days before the LT~* Recipients submitted to multiple organ transplantation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Strict Glycemic Control Group (Type: ACTIVE_COMPARATOR): Intravenous insulin as described by Keegan and Cols. 2010.
- Standard Glycemic Control Group (Type: ACTIVE_COMPARATOR): Subcutaneous insulin as instititional protocol.

Based on this trial design, predict the completion outcome and termination type (if applicable).